Major advances in the treatment of stroke

Nature Reviews Neurology

Volumn 9, Issue 2, 2013, Pages 68-70

  Blanco, Miguel ^a   Castillo, José ^a  

^a Clinical Neurosciences Research Laboratory   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; CITICOLINE; PLACEBO; WARFARIN; FIBRINOLYTIC AGENT; NEUROPROTECTIVE AGENT;

BARTHEL INDEX; BRAIN ISCHEMIA; CARDIAC EQUIPMENT; CEREBROVASCULAR ACCIDENT; EMBOLISM; EMBRYONIC STEM CELL; FIBRINOLYTIC THERAPY; HEART ATRIUM FIBRILLATION; HUMAN; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROPROTECTION; NONHUMAN; PATENT FORAMEN OVALE; PERCUTANEOUS CLOSURE DEVICE; PLURIPOTENT STEM CELL; PRIMARY PREVENTION; PRIORITY JOURNAL; RANKIN SCALE; REVIEW; SECONDARY PREVENTION; STEM CELL TRANSPLANTATION; SUPRAVENTRICULAR TACHYCARDIA; TRANSIENT ISCHEMIC ATTACK; ANIMAL; CLINICAL TRIAL (TOPIC); MOUSE; NEUROSURGERY;

ANIMALS; BRAIN ISCHEMIA; CLINICAL TRIALS AS TOPIC; FIBRINOLYTIC AGENTS; FORAMEN OVALE, PATENT; HUMANS; MICE; NEUROPROTECTIVE AGENTS; NEUROSURGERY; STEM CELL TRANSPLANTATION; STROKE; THROMBOLYTIC THERAPY;

MLCS; MLOWN;

EID: 84873715514     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2012.274     Document Type: Review

References (19)

1. Engel, J. Jr et al. Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial. JAMA 307, 922-930 (2012).
2. Engel, J. Jr et al. Design considerations for a multicenter randomized controlled trial of early surgery for mesial temporal lobe epilepsy. Epilepsia 51, 1978-1986 (2010).
3. French, J. A. et al. Characteristics of medial temporal lobe epilepsy: I. Results of history and physical examination. Ann. Neurol. 34, 774-780 (1993). (Pubitemid 23357889)
4. Berg, A. T., Shinnar, S., Levy, S. R. & Testa, F. M. Childhood-onset epilepsy with and without preceding febrile seizures. Neurology 53, 1742-1748 (1999). (Pubitemid 29530349)
5. Shinnar, S. et al. MRI abnormalities following febrile status epilepticus in children: the FEBSTAT study. Neurology 79, 871-877 (2012).
6. Lee, H. Y. et al. Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions. Cell Rep. 1, 2-12 (2012).
7. Heron, S. E. et al. PRRT2 mutations cause benign familial infantile epilepsy and infantile convulsions with choreoathetosis syndrome. Am. J. Hum. Genet. 90, 152-160 (2012).
8. Cloarec, R. et al. PRRT2 links infantile convulsions and paroxysmal dyskinesia with migraine. Neurology 79, 2097-2103 (2012).
9. Poduri, A. et al. Somatic activation of AKT3 causes hemispheric developmental brain malformations. Neuron 74, 41-48 (2012).
10. Lee, J. H. et al. De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly. Nat. Genet. 44, 941-945 (2012)
11. .Sandercock, P. et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST 3]): a randomised controlled trial. Lancet 379, 2352-2363 (2012).
12. Dávalos, A. et al. Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial). Lancet 380, 349-357 (2012).
13. Dávalos, A. et al. Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials. Stroke 33, 2850-2857 (2002). (Pubitemid 35462855)
14. Healey, J. S. et al. Subclinical atrial fibrillation and the risk of stroke. N. Engl. J. Med. 366, 120-129 (2012).
15. Wolf, P. A., Abbott, R. D. & Kannel, W. B. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22, 983-988 (1991).
16. Lamy, C. et al. Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA Study. Stroke 33, 706-711 (2002). (Pubitemid 34203994)
17. Furlan, A. J. et al. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N. Engl. J. Med. 366, 991-999 (2012).
18. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676 (2006). (Pubitemid 44233629)
19. Oki, K. et al. Human-induced pluripotent stem cells form functional neurons and improve recovery after grafting in stroke-damaged brain. Stem Cells 30, 1120-1133 (2012).